Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Breast Cancer

Free Subscription Articles published in Int J Radiat Oncol Biol Phys Retrieve available abstracts of 99 articles: HTML format

Single Articles

January 2026
1. BOURGIER C, Mollevi C, Cowen D, Castan F, et al
   Late Toxicities and Quality of Life After a Radiation Boost for Breast Ductal Carcinoma In Situ: Boost or No Boost in DCIS Randomized Trial.
   Int J Radiat Oncol Biol Phys. 2026;124:109-121.
   PubMed     Abstract available
   
   
   December 2025
2. DAGAR A, Ghosh A, Singhal A, Kumar A, et al
   A study of curative approach treatment along with metastasis-directed SBRT in bone-only oligometastatic breast cancer.
   Int J Radiat Oncol Biol Phys. 2025 Dec 11:S0360-3016(25)06534.
   PubMed     Abstract available
   
   
   
3. BEYER S, Hawley J, Gokun Y, Yildiz VO, et al
   Use of MRI to Guide Pre-op APBI in the Prone Position and Treatment Response in Clinical Stage 1 Hormone Sensitive Breast Cancer: A Phase I/II Study.
   Int J Radiat Oncol Biol Phys. 2025 Dec 6:S0360-3016(25)06529.
   PubMed     Abstract available
   
   
   
4. FUKUMITSU N, Shiba S, Shibuya K, Kobayashi D, et al
   Comprehensive Analysis of Data From a Nationwide Japanese Cohort on Particle Therapy for Metastatic Liver Tumors.
   Int J Radiat Oncol Biol Phys. 2025;123:1316-1322.
   PubMed     Abstract available
   
   
   November 2025
5. UNTERKIRHERS S, Erni S, Gruber G, Schneider U, et al
   Poisson LQ TCP Model Validation in Micro- and Macroscopic Breast-Cancer Radiotherapy.
   Int J Radiat Oncol Biol Phys. 2025 Nov 23:S0360-3016(25)06482.
   PubMed     Abstract available
   
   
   
6. HYUCK JEON S, Park N, Kim Y, Kim JH, et al
   Radiotherapy increases circulating early-stage natural killer cells with enhanced cytokine responsiveness in breast cancer.
   Int J Radiat Oncol Biol Phys. 2025 Nov 20:S0360-3016(25)06486.
   PubMed     Abstract available
   
   
   
7. NANGIA S
   Calculation of the absolute risk of a radiation-induced acute coronary event in breast cancer patients: a hypothesis incorporating Indian ethnicity.
   Int J Radiat Oncol Biol Phys. 2025 Nov 20:S0360-3016(25)06479.
   PubMed     Abstract available
   
   
   
8. ARIF A, Khan AJ
   Pre-operative Radiotherapy in Locally Advanced Breast Cancer: A Narrative Review.
   Int J Radiat Oncol Biol Phys. 2025 Nov 17:S0360-3016(25)06437.
   PubMed     Abstract available
   
   
   
9. VICINI F, Shah C, Mittal K, Weinmann S, et al
   Limitations in the Application of Clinicopathologic Factors Alone in Predicting Radiation Benefit for Women With Low-Risk Ductal Carcinoma In Situ After Breast Conserving Surgery: The Impact of a 7-Gene Biosignature Based on 10-Year Ipsilateral Breast
   Int J Radiat Oncol Biol Phys. 2025;123:1090-1101.
   PubMed     Abstract available
   
   
   
10. HARISH M DR, Sethi P Dr, Gunaseelan K Dr, Maroju NK Dr, et al
    Effectiveness of low-cost polyurethane film in reducing dermatitis severity in breast cancer patients with higher Fitzpatrick skin types undergoing hypofractionated irradiation with simultaneous integrated boost: An intrapatient randomized controlled
    Int J Radiat Oncol Biol Phys. 2025 Nov 2:S0360-3016(25)06422.
    PubMed     Abstract available
    
    
    
11. WADASADAWALA T, Syeda N, Kenekar S, Krishnamurthy R, et al
    Cumulative Risk of Cosmetic Worsening Following Ultrahypofractionated Whole Breast Radiation Therapy With Simultaneous Integrated Boost: The Largest Real-World Data.
    Int J Radiat Oncol Biol Phys. 2025;123:732-741.
    PubMed     Abstract available
    
    
    
12. LOAP P, Loirat D, Stern MH, Pierga JY, et al
    Safety and Potential Radiosensitizing Effect of Olaparib in Combination With Breast Radiation Therapy for Patients With Triple-Negative Breast Cancer With Residual Disease: Long-Term Results From the RADIOPARP Phase 1 Trial.
    Int J Radiat Oncol Biol Phys. 2025;123:726-731.
    PubMed     Abstract available
    
    
    October 2025
13. FACONDO G, Reverberi C, Prisco A, Ceschia T, et al
    Post-Operative Single Fraction Stereotactic Partial Breast Irradiation (S-PBI) for Early-Stage Breast Cancer with Gammapod Technology: A Phase II Clinical Trial.
    Int J Radiat Oncol Biol Phys. 2025 Oct 27:S0360-3016(25)06400.
    PubMed     Abstract available
    
    
    
14. WRIGHT JL, Croke J, Kirova Y, Braunstein LZ, et al
    Less Is More: Current Trials Redefining Locoregional Therapy in Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2025;123:323-327.
    PubMed    
    
    
    September 2025
15. TELES MS, Lapen K, Huang J, Mao JJ, et al
    Assessing the Implementation of Electronic Patient-Reported Outcomes (ePRO) to Reduce Follow-up Visits for Patients Undergoing Radiation Therapy for Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2025 Sep 28:S0360-3016(25)06289.
    PubMed     Abstract available
    
    
    
16. STECKLEIN SR, Salgado R, White JR, Kimler BF, et al
    Analysis of the Radiosensitivity Index (RSI) in Paired Pre- and Post-Neoadjuvant Therapy Triple-Negative Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2025 Sep 25:S0360-3016(25)06302.
    PubMed     Abstract available
    
    
    
17. GUNSTER JLB, Groen EJ, Salgado R, Marijnen CAM, et al
    Tumor-infiltrating lymphocytes and preoperative partial breast irradiation in early-stage breast cancer: insights from the prospective PAPBI cohort.
    Int J Radiat Oncol Biol Phys. 2025 Sep 11:S0360-3016(25)06205.
    PubMed     Abstract available
    
    
    
18. LAKOMY DS, Kennedy WR, Laugeman E, Huang Y, et al
    Long-Term Results of a Phase II Prospective Clinical Trial of Single-Fraction, High-Gradient Adjuvant Partial Breast Irradiation in Early-Stage, Hormone Positive Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2025 Sep 3:S0360-3016(25)06004.
    PubMed     Abstract available
    
    
    
19. NICHOL A, Wade L, Gondara L, Musoke R, et al
    A Matched Case-Control Study of the Relationship Between Radiation Dose to the Internal Mammary Lymph Nodes and Clinical Outcomes in Patients With and Without Internal Mammary Lymph Node Relapses.
    Int J Radiat Oncol Biol Phys. 2025;123:150-160.
    PubMed     Abstract available
    
    
    August 2025
20. YADAV DBS, Goyal DS, Dahiya DD, Vias DP, et al
    HYPofractionated Adjuvant RadioTherapy in 1 versus 2 weeks in high-risk patients with breast cancer (HYPART): Acute toxicity results.
    Int J Radiat Oncol Biol Phys. 2025 Aug 6:S0360-3016(25)06045.
    PubMed     Abstract available
    
    
    
21. LEVIN D, Shekel E, Rosenfeld H, Grinfeld G, et al
    Beyond Technology: The Impact of Personal Physics Consultation on Patient Anxiety in Breast Cancer Radiotherapy.
    Int J Radiat Oncol Biol Phys. 2025 Aug 4:S0360-3016(25)06044.
    PubMed     Abstract available
    
    
    
22. RASH D, Anderson B
    Prone Positioning for Regional Nodal Irradiation in Breast Cancer: Are We Ready for This?
    Int J Radiat Oncol Biol Phys. 2025;122:1140-1142.
    PubMed    
    
    
    
23. CLASEN SC, Bazan J, Bergom C
    Impact of Cardiac Radiation Dose on Cardiotoxicity in Patients With Breast Cancer Undergoing Adjuvant Trastuzumab Therapy.
    Int J Radiat Oncol Biol Phys. 2025;122:1125-1127.
    PubMed    
    
    
    
24. PURSWANI JM, Maisonet O, Xiao J, Teruel JR, et al
    Phase 1-2 Study of Prone Hypofractionated Accelerated Breast and Nodal Intensity Modulated Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2025;122:1128-1139.
    PubMed     Abstract available
    
    
    
25. GOMA C, Molla M, Oses G, Sanfeliu E, et al
    Preoperative Radiotherapy-Induced Molecular and Immune Modulation in Early-Stage Breast Cancer: Results from the YOUNGSTER Trial.
    Int J Radiat Oncol Biol Phys. 2025 Aug 1:S0360-3016(25)06042.
    PubMed     Abstract available
    
    
    July 2025
26. PARSONS D, Domal S, Chambers E, Salazar D, et al
    Feasibility and Impact of a Radiation Therapy Technologist-Driven Workflow for Cone Beam Computed Tomography Guided Partial Breast Adaptive Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2025;122:893-901.
    PubMed     Abstract available
    
    
    June 2025
27. LOAP P, Fakih AE, Helal C, Cabel L, et al
    Cardiac outcomes following adjuvant radiotherapy in triple-negative breast cancer patients with prior autoimmune myocarditis.
    Int J Radiat Oncol Biol Phys. 2025 Jun 15:S0360-3016(25)03909.
    PubMed     Abstract available
    
    
    
28. PAWLOSKI KR, Xu A, Diskin B, Sevilimedu V, et al
    Once-Daily Postmastectomy Radiation Therapy Confers Excellent Locoregional Control for Inflammatory Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2025 Jun 12:S0360-3016(25)00592.
    PubMed     Abstract available
    
    
    
29. TERRY AR, Boe L, Pawloski KR, O'Brien DR, et al
    Partial Breast Irradiation for High Molecular Risk Early-Stage Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2025 Jun 12:S0360-3016(25)00486.
    PubMed     Abstract available
    
    
    
30. CHOI JI, Rodin D, Patel R, Sparano J, et al
    Salvage Therapy for Isolated Local-Regional Breast Cancer Recurrence.
    Int J Radiat Oncol Biol Phys. 2025 Jun 11:S0360-3016(25)00593.
    PubMed     Abstract available
    
    
    
31. IYER P
    Locally Advanced Breast Cancer: A Systemic Disease with a Locoregional Symptom Burden. Is it Time to Challenge the "No Local Treatment" Stereotype?
    Int J Radiat Oncol Biol Phys. 2025;122:292-293.
    PubMed    
    
    
    
32. NAOUM GE, Dobinda K, Yalamanchili A, Ho A, et al
    Protons Versus Photons Postmastectomy Radiation Therapy Effects on Breast Reconstruction Outcomes and Dosimetry Analysis.
    Int J Radiat Oncol Biol Phys. 2025;122:249-266.
    PubMed     Abstract available
    
    
    
33. GERBER NK, Sheng JY, Thompson A, Wright J, et al
    Multimodality Treatment De-Intensification in Node-Negative, Hormone-Receptor Breast Cancer: What Are the Limits?
    Int J Radiat Oncol Biol Phys. 2025 Jun 1:S0360-3016(25)00551.
    PubMed     Abstract available
    
    
    May 2025
34. HONG SW, Kim EK, Shin HC, Beom J, et al
    Relationship of Immediate Breast Reconstruction and the Development of Lymphedema in Breast Cancer Patients with Radiotherapy.
    Int J Radiat Oncol Biol Phys. 2025 May 25:S0360-3016(25)00531.
    PubMed     Abstract available
    
    
    
35. SHI W, Zhang L, Li Z, Zhao X, et al
    Association of Multi-Kingdom Skin Microbiota With Radiation Dermatitis in Patients With Breast Cancer After Reconstructive Surgery: A Prospective, Longitudinal Study.
    Int J Radiat Oncol Biol Phys. 2025 May 6:S0360-3016(25)00350.
    PubMed     Abstract available
    
    
    
36. POPPE MM, Boucher K, Gaffney DK, Brownson KE, et al
    NOVEMBER, A Phase 2 Trial of a 9-Day Course of Whole Breast Radiation Therapy With a Simultaneous Lumpectomy Boost for Early-Stage Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2025 May 2:S0360-3016(25)00348.
    PubMed     Abstract available
    
    
    
37. KIM N, Kim SS, Cho WK, Park W, et al
    Concurrent Versus Sequential Adjuvant Capecitabine-Based Chemoradiation in Residual Triple-Negative Breast Cancer After Neoadjuvant-Chemotherapy: A Multicenter Comparative Study.
    Int J Radiat Oncol Biol Phys. 2025;122:72-83.
    PubMed     Abstract available
    
    
    April 2025
38. NAOUM GE, Ababneh HS, Niemierko A, Salama L, et al
    Impact of Prepectoral Implant Placement and Radiation Modalities (Protons/Photons/Dosimetry) in Mastectomy Patients Undergoing Immediate Single Stage Direct-to-Implant Breast Reconstruction.
    Int J Radiat Oncol Biol Phys. 2025;121:1156-1167.
    PubMed     Abstract available
    
    
    March 2025
39. TAGHIAN AG, Naoum GE, Braunstein LZ, Niemierko A, et al
    Defining the Optimal Dose for 3-Dimensional Conformal Accelerated Partial Breast Irradiation: 15-Year Follow-Up of a Dose-Escalation Trial.
    Int J Radiat Oncol Biol Phys. 2025;121:900-909.
    PubMed     Abstract available
    
    
    
40. BRAUNSTEIN LZ, Boe L, Mueller B, Obrien DR, et al
    Accelerated Partial Breast Irradiation for Early-Stage Invasive Lobular Carcinoma.
    Int J Radiat Oncol Biol Phys. 2025;121:894-899.
    PubMed     Abstract available
    
    
    
41. YANG K, Zhang Y, Li S, Chen L, et al
    Multimodal Photoacoustic/Elastography Imaging for the Detection of Acute Radiation Dermatitis in Breast Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2025;121:910-917.
    PubMed     Abstract available
    
    
    
42. DZHUGASHVILI M, Serradilla A, Fernandez-Ibiza J, Garcia G, et al
    Ultrahypofractionation and Simultaneous Integrated Boost in Breast Cancer: Early Side Effects Analysis.
    Int J Radiat Oncol Biol Phys. 2025 Mar 10:S0360-3016(25)00141.
    PubMed     Abstract available
    
    
    
43. BAI J, Gong C, Hu YJ, Bruner DW, et al
    Skin Microbiome, Inflammation, and Skin Toxicities in Women With Breast Cancer Receiving Moderately Hypofractionated Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2025 Mar 8:S0360-3016(25)00194.
    PubMed     Abstract available
    
    
    
44. TELLO VALVERDE CP, Bakker A, Kok HP, Kolff MW, et al
    The Probability of Locoregional Control in Patients With Locoregional Recurrent Breast Cancer Treated With Postoperative Reirradiation and Hyperthermia (RADHY): A Continuous Thermal Dose-effect Relationship.
    Int J Radiat Oncol Biol Phys. 2025 Mar 7:S0360-3016(25)00176.
    PubMed     Abstract available
    
    
    
45. SHAITELMAN SF
    ABLATIVE Radiation Therapy for Breast Cancer: The Time Has Come for Innovation.
    Int J Radiat Oncol Biol Phys. 2025;121:623-625.
    PubMed    
    
    
    
46. VINASCO-SANDOVAL T, Moratille S, Crechet F, Mesloub Y, et al
    Long Noncoding VIM-AS1: Biomarker of Breast Fibrosis Susceptibility After Radiation Therapy and Promoter of Transforming Growth Factor Beta1-Driven Fibrosis.
    Int J Radiat Oncol Biol Phys. 2025;121:783-797.
    PubMed     Abstract available
    
    
    
47. CIVIL YA, Vasmel JE, Charaghvandi RK, Houweling AC, et al
    Preoperative Magnetic Resonance Guided Single-Dose Partial Breast Irradiation: 5-Year Results of the Prospective Single-Arm ABLATIVE Trial.
    Int J Radiat Oncol Biol Phys. 2025;121:613-622.
    PubMed     Abstract available
    
    
    
48. MA J, Shah R, Bell AC, McDermott N, et al
    Increased Synthetic Cytotoxicity of Combinatorial Chemoradiation Therapy in Homologous Recombination Deficient Tumors.
    Int J Radiat Oncol Biol Phys. 2025;121:768-779.
    PubMed     Abstract available
    
    
    February 2025
49. SALARI K, Lee JS, Mumaw DA, Almahariq MF, et al
    Regional Near-surface Dose Predicts Moist Desquamation and Implant Failure in Patients Receiving Radiation Therapy for Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2025 Feb 24:S0360-3016(25)00148.
    PubMed     Abstract available
    
    
    
50. REVERBERI C, Facondo G, Prisco A, Ceschia T, et al
    Pre-Operative Single Fraction Stereotactic Partial Breast Irradiation (S-PBI) for Early-Stage Breast Cancer Patients with Gammapod Technology: Pathological Findings and Ki-67 Evaluation.
    Int J Radiat Oncol Biol Phys. 2025 Feb 22:S0360-3016(25)00152.
    PubMed     Abstract available
    
    
    
51. MUTTER RW, Golafshar MA, Buras MR, Comstock BP, et al
    Dose Deintensified 3-Day Photon, Proton, or Brachytherapy: A Nonrandomized Controlled Partial Breast Irradiation Trial.
    Int J Radiat Oncol Biol Phys. 2025;121:352-364.
    PubMed     Abstract available
    
    
    
52. GLICKSMAN RM, Raman S, Ye XY, Bedard PL, et al
    The Role of Stereotactic Body Radiotherapy in Oligoprogressive Malignant Disease (RADIANT): Oncologic Outcomes From a Phase 2 Nonrandomized Controlled Trial.
    Int J Radiat Oncol Biol Phys. 2025;121:292-306.
    PubMed     Abstract available
    
    
    
53. DECKER SM, Bruza P, Zhang R, Pogue BW, et al
    Visual Dose Monitoring for Whole Breast Radiation Therapy Treatments via Combined Cherenkov Imaging and Scintillation Dosimetry.
    Int J Radiat Oncol Biol Phys. 2025;121:365-374.
    PubMed     Abstract available
    
    
    January 2025
54. MORRIS AD, Hanes DA, Kaplan HG
    Long-Term Outcomes of Radiation Monotherapy Versus Combined Radiation Monotherapy + Hormone Therapy in Low-Risk Early-Stage Breast Cancer Patients 70 Years or Older After Breast-Conserving Surgery.
    Int J Radiat Oncol Biol Phys. 2025 Jan 24:S0360-3016(24)03705.
    PubMed     Abstract available
    
    
    
55. CAO J, Yassa M, Bolivar CHA, Dahn H, et al
    Modified Delphi Consensus on Interventions for Acute Radiation Dermatitis in Breast Cancer: A Canadian Expert Perspective.
    Int J Radiat Oncol Biol Phys. 2025 Jan 10:S0360-3016(25)00022.
    PubMed     Abstract available
    
    
    
56. ROBERTI S, Russell NS, Pfeiffer RM, Krul IM, et al
    Radiation doses to the breast and predicted breast cancer risk among patients treated for Hodgkin lymphoma with modern radiotherapy.
    Int J Radiat Oncol Biol Phys. 2025 Jan 8:S0360-3016(24)03775.
    PubMed     Abstract available
    
    
    
57. SCHELLENBERG D, Gabos Z, Duimering A, Debenham B, et al
    Stereotactic Ablative Radiation for Oligoprogressive Cancers: Results of the Randomized Phase 2 STOP Trial.
    Int J Radiat Oncol Biol Phys. 2025;121:28-38.
    PubMed     Abstract available
    
    
    
58. SHAITELMAN SF, Le-Petross H, Raso MG, Swanson DM, et al
    PRECISE: Preoperative Radiation Therapy to Elicit Critical Immune Stimulating Effects-A Phase 2 Clinical Trial.
    Int J Radiat Oncol Biol Phys. 2025;121:90-96.
    PubMed     Abstract available
    
    
    December 2024
59. LEE J, Byun HK, Kim YT, Shin J, et al
    A study on BReast cancer patient care using chAtbot and Video Education for radiation therapy (BRAVE): A randomized controlled trial.
    Int J Radiat Oncol Biol Phys. 2024 Dec 26:S0360-3016(24)03732.
    PubMed     Abstract available
    
    
    
60. DENG XW, Zhao HM, Jia LC, Li JN, et al
    Prior Knowledge-Guided U-Net for Automatic CTV Segmentation in Postmastectomy Radiotherapy of Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2024 Dec 10:S0360-3016(24)03711.
    PubMed     Abstract available
    
    
    
61. LOAP P, Kirova Y, Braunstein LZ
    Honing Locoregional Therapy for Breast Cancer: Refinement of Surgical and Radiotherapeutic Management.
    Int J Radiat Oncol Biol Phys. 2024;120:1199-1204.
    PubMed    
    
    
    November 2024
62. LEE SF, Yip PL, Spencer S, Ho H, et al
    StrataXRT and Mepitel Film for preventing post-mastectomy acute radiation dermatitis in breast cancer: an intra-patient non-inferiority randomized clinical trial.
    Int J Radiat Oncol Biol Phys. 2024 Nov 26:S0360-3016(24)03656.
    PubMed     Abstract available
    
    
    
63. DOHOPOLSKI M, Schmitt LG, Anand S, Zhang H, et al
    Exploratory Evaluation of Personalized Ultra-Fractionated Stereotactic Adaptive Radiotherapy (PULSAR) with CNS-Active Drugs in Brain Metastases Treatment.
    Int J Radiat Oncol Biol Phys. 2024 Nov 16:S0360-3016(24)03641.
    PubMed     Abstract available
    
    
    
64. CORRIGAN KL, Bankston ME, Holliday EB, Shaitelman SF, et al
    Disease Site Specialization in the Academic Radiation Oncology Workforce: Evidence of Gender Differences.
    Int J Radiat Oncol Biol Phys. 2024;120:936-939.
    PubMed     Abstract available
    
    
    
65. COSTA IM, Firth G, Kim J, Banu A, et al
    In Vitro and Preclinical Systematic Dose-Effect Studies of Auger Electron- and beta Particle-Emitting Radionuclides and External Beam Radiation for Cancer Treatment.
    Int J Radiat Oncol Biol Phys. 2024;120:1124-1134.
    PubMed     Abstract available
    
    
    
66. LEE TH, Kim N, Kim EK, Ahn JS, et al
    Significant Influence of Cardiac Radiation Dose on the Risk of Cardiotoxicity in Patients Receiving Adjuvant Trastuzumab and Radiation Therapy for Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2024 Nov 14:S0360-3016(24)03583.
    PubMed     Abstract available
    
    
    
67. JACOMINA LE, Swanson DM, Mitchell MP, Woodward WA, et al
    Outcomes After Palliative Radiotherapy in Patients with Symptomatic Locoregionally Advanced Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2024 Nov 14:S0360-3016(24)03637.
    PubMed     Abstract available
    
    
    October 2024
68. REDDY JP, Sherry AD, Fellman B, Liu S, et al
    Adding Metastasis-Directed Therapy to Standard-of-Care Systemic Therapy for Oligometastatic Breast Cancer (EXTEND): a Multicenter, Randomized Phase II Trial.
    Int J Radiat Oncol Biol Phys. 2024 Oct 30:S0360-3016(24)03522.
    PubMed     Abstract available
    
    
    
69. HEALY E, Bazan JG
    A Boost in the Wrong Direction? Rethinking Escalated Approaches for Ductal Carcinoma In Situ.
    Int J Radiat Oncol Biol Phys. 2024;120:317.
    PubMed    
    
    
    
70. SHAH C, Tendulkar R
    The Role of Boost in Ductal Carcinoma In Situ: A Partial Answer?
    Int J Radiat Oncol Biol Phys. 2024;120:316.
    PubMed    
    
    
    
71. BASREE MM, Blitzer GC
    Boosting the Odds: Navigating Fraction Options in the Ductal Carcinoma In Situ Odyssey.
    Int J Radiat Oncol Biol Phys. 2024;120:315.
    PubMed    
    
    
    September 2024
72. KIM N, Park W, Kim H, Cho WK, et al
    Patient-reported outcomes between whole-breast plus regional irradiation and whole-breast irradiation only in pN1 breast cancer after breast conserving surgery and taxane-based chemotherapy: A randomized phase 3 clinical trial (KROG 17-01).
    Int J Radiat Oncol Biol Phys. 2024 Sep 24:S0360-3016(24)03392.
    PubMed     Abstract available
    
    
    
73. YEHIA ZA, Sherwani Z, Chakraborty M, Ohri N, et al
    First Results of the Primary Outcome of a Phase II Prospective Clinical Trial to Assess the Feasibility of Preoperative Radiation Boost in Breast Cancer Patients.
    Int J Radiat Oncol Biol Phys. 2024 Sep 4:S0360-3016(24)03320.
    PubMed     Abstract available
    
    
    
74. RODIN D, Glicksman RM, Hepel JT, Huber K, et al
    Early-Stage Breast Cancer: A Critical Review of Current and Emerging Practice.
    Int J Radiat Oncol Biol Phys. 2024 Sep 3:S0360-3016(24)03293.
    PubMed     Abstract available
    
    
    August 2024
75. SPEERS C, Anderson B
    Can Less Be More? Evolving Strategies for Therapy De-escalation in Early-Stage Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2024;119:1327-1330.
    PubMed    
    
    
    
76. LEE BM, Kim JS, Chang Y, Choi SH, et al
    Experience of Implementing Deep Learning-Based Automatic Contouring in Breast Radiation Therapy Planning: Insights From Over 2000 Cases.
    Int J Radiat Oncol Biol Phys. 2024;119:1579-1589.
    PubMed     Abstract available
    
    
    
77. FAERMANN R, Sklair-Levy M, Shalmon A, Halshtok Neiman O, et al
    Incidental Axillary Lymphadenopathy Found on Radiation Planning Computed Tomography.
    Int J Radiat Oncol Biol Phys. 2024;119:1464-1470.
    PubMed     Abstract available
    
    
    
78. MARKAN U, Baker K, Eggleston C, Cheston SB, et al
    Psychosocial Factors That Influence a Woman's Decision to Enroll in a Clinical Trial: Implications on How to Improve Clinical Trial Enrollment Among Black Women.
    Int J Radiat Oncol Biol Phys. 2024;119:1347-1356.
    PubMed     Abstract available
    
    
    July 2024
79. BEYDOUN H, Griffith KA, Jagsi R, Burmeister JW, et al
    Are We Missing Acute Toxicities Associated With Hypofractionated Breast Irradiation? A Report From a Large Multicenter Cohort Study.
    Int J Radiat Oncol Biol Phys. 2024;119:1092-1098.
    PubMed     Abstract available
    
    
    
80. ASHA W, Al-Hilli Z, Djohan R, Budd GT, et al
    Neoadjuvant Reirradiation for Radiation Therapy-Associated Angiosarcoma of the Breast.
    Int J Radiat Oncol Biol Phys. 2024;119:1082-1085.
    PubMed     Abstract available
    
    
    
81. HEPEL JT, Leonard KL, Yashar CM, Einck JP, et al
    Phase II Trial of Five-Fraction Accelerated Partial Breast Irradiation Using Noninvasive Image-Guided Breast Brachytherapy.
    Int J Radiat Oncol Biol Phys. 2024;119:878-883.
    PubMed     Abstract available
    
    
    June 2024
82. YIT LFN, Quek ZHS, Tan JYT, Tan BF, et al
    Curative Approaches for Metaplastic Breast Cancer: A Retrospective Cohort Outcome Review.
    Int J Radiat Oncol Biol Phys. 2024 Jun 29:S0360-3016(24)00751.
    PubMed     Abstract available
    
    
    
83. ZHOU YY, Li YN, Xu JF, Chen B, et al
    Rapid Selection of Patients Suitable for Deep Inspiration Breath-Hold Using an Automatic Delineating System and RapidPlan Model in Left Breast Cancer Patients undergoing Adjuvant Radiotherapy with IMRT.
    Int J Radiat Oncol Biol Phys. 2024 Jun 26:S0360-3016(24)00739.
    PubMed     Abstract available
    
    
    
84. LO AC, Ronckers C, Aznar MC, Avanzo M, et al
    Breast Hypoplasia and Decreased Lactation From Radiation Therapy in Survivors of Pediatric Malignancy: A PENTEC Comprehensive Review.
    Int J Radiat Oncol Biol Phys. 2024;119:549-559.
    PubMed     Abstract available
    
    
    May 2024
85. HAHN EA, Pugh SL, Lu HL, Vela AM, et al
    Validation of Patient-Reported Outcomes in Patients With Nonmetastatic Breast Cancer Receiving Comprehensive Nodal Irradiation in the RadComp Trial.
    Int J Radiat Oncol Biol Phys. 2024 May 13:S0360-3016(24)00436.
    PubMed     Abstract available
    
    
    
86. KOLEOSO O, Toumbacaris N, Brogi E, Zhang Z, et al
    The presence of extensive lymphovascular invasion (LVI) is associated with higher risks of local-regional recurrence compared to usual LVI in curatively treated breast cancer patients.
    Int J Radiat Oncol Biol Phys. 2024 May 4:S0360-3016(24)00625.
    PubMed     Abstract available
    
    
    April 2024
87. YONEYAMA M, Zormpas-Petridis K, Robinson R, Sobhani F, et al
    Longitudinal assessment of tumor-infiltrating lymphocytes in primary breast cancer following neoadjuvant radiotherapy.
    Int J Radiat Oncol Biol Phys. 2024 Apr 26:S0360-3016(24)00566.
    PubMed     Abstract available
    
    
    
88. KIM E, Yoo JS, Kim YJ, Joo J, et al
    Toxicity evaluation of dose-escalation in hypofractionated regional nodal irradiation for breast cancer: a retrospective study.
    Int J Radiat Oncol Biol Phys. 2024 Apr 15:S0360-3016(24)00513.
    PubMed     Abstract available
    
    
    
89. ROGE M, Kirova Y, Leveque E, Guigo M, et al
    Impact of radiation therapy modalities on loco-regional control in inflammatory breast cancer.
    Int J Radiat Oncol Biol Phys. 2024 Apr 13:S0360-3016(24)00506.
    PubMed     Abstract available
    
    
    
90. LOVING BA, Almahariq MF, Sivapalan S, Levitin R, et al
    Newly Diagnosed Mental Health Disorders in Patients with Breast Cancer Receiving Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2024 Apr 4:S0360-3016(24)00445.
    PubMed     Abstract available
    
    
    
91. KIROVA YM, Loap P
    Improving the Treatment of Brain Metastases in HER2-Positive Breast Cancers: Eternal Dream or Reality? Results of the NRG Oncology-KROG/RTOG 1119 Phase 2 Randomized Trial and Future Directions.
    Int J Radiat Oncol Biol Phys. 2024;118:1402-1403.
    PubMed    
    
    
    
92. KHAN AJ, Marine CB, Flynn J, Tyagi N, et al
    A Phase II Study Evaluating the Effect of Intensity-Modulated Post-Mastectomy Radiation Therapy on Implant Failure Rates in Breast Cancer Patients with Immediate, 2-Stage Implant Reconstruction, with an MRI imaging correlative substudy.
    Int J Radiat Oncol Biol Phys. 2024 Apr 1:S0360-3016(24)00451.
    PubMed     Abstract available
    
    
    March 2024
93. SHEVA K, Chowdhury SR, Kravchenko-Balasha N, Meirovitz A, et al
    Molecular changes in breast cancer induced by radiation therapy.
    Int J Radiat Oncol Biol Phys. 2024 Mar 18:S0360-3016(24)00435.
    PubMed     Abstract available
    
    
    
94. SILVERWOOD S, Lichter K, Conway A, Drew T, et al
    Distance Traveled by Patients Globally to Access Radiation Therapy: A Systematic Review.
    Int J Radiat Oncol Biol Phys. 2024;118:891-899.
    PubMed     Abstract available
    
    
    
95. LAUGHLIN BS, Corbin KS, Toesca DAS, Thorpe CS, et al
    Physician- and Patient-Reported Outcomes of the MC1635 Phase 3 Trial of Ultrahypofractionated Versus Moderately Hypofractionated Adjuvant Radiation Therapy After Breast-Conserving Surgery.
    Int J Radiat Oncol Biol Phys. 2024;118:1049-1059.
    PubMed     Abstract available
    
    
    
96. GRENDAROVA P, Roumeliotis M, Quirk S, Phan T, et al
    Accelerated Partial Breast Irradiation Using 5 Daily Fractions: A Prospective, Phase 2, Multicenter Trial of Cosmetic Outcomes and Toxicity-ACCEL Final Results.
    Int J Radiat Oncol Biol Phys. 2024;118:1041-1048.
    PubMed     Abstract available
    
    
    
97. BEHZADI ST, Moser R, Kiesl S, Nano J, et al
    Tumor Contact with Internal Mammary Perforator Vessels as Risk Factor for Gross Internal Mammary Lymph Node Involvement in Breast Cancer Patients.
    Int J Radiat Oncol Biol Phys. 2024 Mar 6:S0360-3016(24)00339.
    PubMed     Abstract available
    
    
    
98. WU VS, Khlopin M, Chadha M, Smith-Graziani DJ, et al
    Out-of-pocket cost modeling of adjuvant antiestrogen and radiation therapy after lumpectomy for early-stage breast cancer across Medicaid and Medicare plans.
    Int J Radiat Oncol Biol Phys. 2024 Mar 1:S0360-3016(24)00351.
    PubMed     Abstract available
    
    
    December 2023
99. PATEL TA, Jain B, Vapiwala N, Chino F, et al
    Trends in Utilization and Medicare Spending on Short-Course Radiotherapy for Breast and Prostate Cancer: An Episode-Based Analysis from 2015-2019.
    Int J Radiat Oncol Biol Phys. 2023 Dec 8:S0360-3016(23)08173.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge.